Detailed information for compound 1566355

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 498.491 | Formula: C23H23N4O5PS
  • H donors: 1 H acceptors: 5 LogP: 4.69 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOP(=O)(C(c1ccc(cc1)c1ccncc1)Nc1nc2c(s1)cc(cc2)[N+](=O)[O-])OCC
  • InChi: 1S/C23H23N4O5PS/c1-3-31-33(30,32-4-2)22(18-7-5-16(6-8-18)17-11-13-24-14-12-17)26-23-25-20-10-9-19(27(28)29)15-21(20)34-23/h5-15,22H,3-4H2,1-2H3,(H,25,26)
  • InChiKey: YVJUADXNQLNLEC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi diaphorase 0.0018 0.0459 0.0596
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0059 0.1881 0.1814
Treponema pallidum fructose-bisphosphate aldolase 0.0295 1 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Trypanosoma cruzi p450 reductase, putative 0.0154 0.5149 1
Giardia lamblia Nitric oxide synthase, inducible 0.0137 0.4548 0.4285
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0095 0.3125 0.6069
Loa Loa (eye worm) flavodoxin family protein 0.0059 0.1881 0.3443
Trypanosoma cruzi NADPH--cytochrome P450 reductase, putative 0.0059 0.1881 0.3033
Loa Loa (eye worm) diaphorase 0.0018 0.0459 0.0588
Brugia malayi Cytochrome b5-like Heme/Steroid binding domain containing protein 0.0018 0.0459 0.0596
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0137 0.4548 0.4502
Loa Loa (eye worm) FAD binding domain-containing protein 0.0095 0.3125 0.5938
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0154 0.5149 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0154 0.5149 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0154 0.5149 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0154 0.5149 1
Trichomonas vaginalis sulfite reductase, putative 0.0154 0.5149 0.5109
Leishmania major cytochrome P450 reductase, putative 0.0137 0.4548 0.8717
Brugia malayi FAD binding domain containing protein 0.0154 0.5149 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0059 0.1881 0.1814
Echinococcus multilocularis NADH cytochrome b5 reductase 3 0.0018 0.0459 0.0702
Echinococcus granulosus cytochrome b5 reductase 4 0.0018 0.0459 0.0702
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0059 0.1881 0.1814
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0154 0.5149 1
Trypanosoma brucei S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0059 0.1881 0.3033
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0154 0.5149 1
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0154 0.5149 1
Schistosoma mansoni cytochrome B5 0.0018 0.0459 0.0891
Plasmodium falciparum nitric oxide synthase, putative 0.0154 0.5149 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0076 0.2483 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0165 0.012
Giardia lamblia Hypothetical protein 0.0137 0.4548 0.4285
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0295 1 1
Plasmodium falciparum NADPH--cytochrome P450 reductase, putative 0.0059 0.1881 0.3033
Schistosoma mansoni cpg binding protein 0.0031 0.0911 0.1768
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0007 0.0105 0.0203
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0154 0.5149 1
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0154 0.5149 1
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0154 0.5149 1
Loa Loa (eye worm) cytochrome b5 reductase 4 0.0018 0.0459 0.0588
Echinococcus multilocularis cpg binding protein 0.0031 0.0911 0.1598
Leishmania major p450 reductase, putative 0.0154 0.5149 1
Schistosoma mansoni cpg binding protein 0.0031 0.0911 0.1768
Schistosoma mansoni cpg binding protein 0.0029 0.0854 0.1658
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba 0.0144 0.4812 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.0029 0.0854 0.1381
Brugia malayi CXXC zinc finger family protein 0.0029 0.0854 0.1388
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0059 0.1881 0.3033
Onchocerca volvulus 0.0029 0.0854 1
Loa Loa (eye worm) hypothetical protein 0.0154 0.5149 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Echinococcus multilocularis methionine synthase reductase 0.0095 0.3125 0.5987
Loa Loa (eye worm) FAD binding domain-containing protein 0.0154 0.5149 1
Echinococcus granulosus cpg binding protein 0.0031 0.0911 0.1598
Plasmodium vivax hypothetical protein, conserved 0.0059 0.1881 0.3033
Schistosoma mansoni NADPH flavin oxidoreductase 0.0078 0.2523 0.49
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0059 0.1881 0.1814
Plasmodium falciparum S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0059 0.1881 0.3033
Treponema pallidum flavodoxin 0.0059 0.1881 0.1491
Echinococcus granulosus methionine synthase reductase 0.0095 0.3125 0.5987
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.0144 0.4812 1
Giardia lamblia Fructose-bisphosphate aldolase 0.0295 1 1
Toxoplasma gondii histone lysine methyltransferase SET1 0.0055 0.1745 0.6356
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0154 0.5149 1
Leishmania major hypothetical protein, conserved 0.0059 0.1881 0.3033
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0062 0.1971 0.3828
Chlamydia trachomatis sulfite reductase 0.0095 0.3125 1
Brugia malayi flavodoxin family protein 0.0154 0.5149 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0154 0.5149 1
Schistosoma mansoni diflavin oxidoreductase 0.0076 0.2483 0.4822
Schistosoma mansoni NADH-cytochrome B5 reductase 0.0018 0.0459 0.0891
Schistosoma mansoni cytochrome P450 reductase 0.0154 0.5149 1
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0059 0.1881 0.3033
Echinococcus granulosus NADH cytochrome b5 reductase 3 0.0018 0.0459 0.0702
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0165 0.012
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0295 1 1
Brugia malayi FAD binding domain containing protein 0.0095 0.3125 0.5941
Plasmodium vivax flavodoxin domain containing protein 0.0137 0.4548 0.8717
Echinococcus granulosus cytochrome b5 reductase 4 0.0018 0.0459 0.0702
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0154 0.5149 1
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0154 0.5149 1
Echinococcus multilocularis cytochrome b5 reductase 4 0.0018 0.0459 0.0702
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.0144 0.4812 0.9281
Brugia malayi flavodoxin family protein 0.0059 0.1881 0.3448
Toxoplasma gondii flavodoxin domain-containing protein 0.0076 0.2483 1

Activities

Activity type Activity value Assay description Source Reference
GI (ADMET) = 0 % Growth inhibition of human HEK293 cells at 1 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
GI (ADMET) = 0.3 % Growth inhibition of human HEK293 cells at 10 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
GI (functional) = 0.9 % Growth inhibition of human K562 cells at 1 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
GI (functional) = 18.9 % Growth inhibition of human K562 cells at 10 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
GI (functional) = 34.4 % Growth inhibition of human COLO205 cells at 1 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
GI (functional) = 48.1 % Growth inhibition of human COLO205 cells at 10 uM after 24 hrs by MTT assay relative to control ChEMBL. 22136905
IC50 (functional) = 10 uM Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay ChEMBL. 22136905
IC50 (functional) = 31 uM Cytotoxicity against human K562 cells after 24 hrs by MTT assay ChEMBL. 22136905

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 22136905

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.